{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:11:56Z","timestamp":1787163116602,"version":"build-2736575974"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bcp.2026.117876","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T16:09:41Z","timestamp":1772899781000},"page":"117876","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Lycorine suppresses cell growth and attenuates stemness through PI3K\/AKT pathway in ovarian cancer"],"prefix":"10.1016","volume":"249","author":[{"given":"Yaoyao","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanlin","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4851-6463","authenticated-orcid":false,"given":"Haiqin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.117876_b0005","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1001\/jama.2025.9495","article-title":"Ovarian Cancer: a Review","volume":"334","author":"Caruso","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.bcp.2026.117876_b0010","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.23.01771","article-title":"Treatment Approaches for Platinum-Resistant Ovarian Cancer","volume":"42","author":"Laurent","year":"2024","journal-title":"JCO"},{"key":"10.1016\/j.bcp.2026.117876_b0015","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1200\/JCO-24-02589","article-title":"Neoadjuvant Chemotherapy for newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update","volume":"43","author":"Gaillard","year":"2025","journal-title":"JCO"},{"key":"10.1016\/j.bcp.2026.117876_b0020","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1056\/NEJMoa2309169","article-title":"Mirvetuximab Soravtansine in FR\u03b1-Positive, Platinum-Resistant Ovarian Cancer","volume":"389","author":"Moore","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2026.117876_b0025","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/s41571-024-00937-4","article-title":"Immunotherapy for ovarian cancer: towards a tailored immunophenotype-based approach","volume":"21","author":"Ghisoni","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bcp.2026.117876_b0030","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12943-025-02345-3","article-title":"A comprehensive overview of ovarian cancer stem cells: correlation with high recurrence rate, underlying mechanisms, and therapeutic opportunities","volume":"24","author":"Alizadeh","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bcp.2026.117876_b0035","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s40425-019-0666-1","article-title":"Ovarian cancer stem cells and macrophages reciprocally interact through the WNT pathway to promote pro-tumoral and malignant phenotypes in 3D engineered microenvironments","volume":"7","author":"Raghavan","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bcp.2026.117876_b0040","article-title":"Deciphering the \u201cRosetta Stone\u201d of ovarian cancer stem cells: Opportunities and challenges. Biochimica et Biophysica Acta (BBA) - Reviews on","volume":"1880","author":"Tan","year":"2025","journal-title":"Cancer"},{"key":"10.1016\/j.bcp.2026.117876_b0045","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.stem.2024.06.003","article-title":"Cancer stem cell mimicry for immune evasion and therapeutic resistance","volume":"31","author":"Saw","year":"2024","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bcp.2026.117876_b0050","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.semcancer.2021.03.038","article-title":"The hallmarks of ovarian cancer stem cells and niches: Exploring their harmonious interplay in therapy resistance","volume":"77","author":"Motohara","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bcp.2026.117876_b0055","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/s41467-024-45698-x","article-title":"Aggresome formation. promotes ASK1\/JNK signaling activation and stemness maintenance in ovarian cancer","volume":"15","author":"Chen","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.117876_b0060","doi-asserted-by":"crossref","first-page":"11042","DOI":"10.18632\/aging.103317","article-title":"Highly expressed STAT1 contributes to the suppression of stemness properties in human paclitaxel-resistant ovarian cancer cells","volume":"12","author":"Wang","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.bcp.2026.117876_b0065","doi-asserted-by":"crossref","DOI":"10.1172\/JCI151591","article-title":"FOXK2 promotes ovarian cancer stemness by regulating the unfolded protein response pathway","volume":"132","author":"Zhang","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2026.117876_b0070","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1038\/onc.2009.500","article-title":"Pluripotency factors Lin28 and Oct4 identify a sub-population of stem cell-like cells in ovarian cancer","volume":"29","author":"Peng","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2026.117876_b0075","doi-asserted-by":"crossref","unstructured":"C. Xiang, L. Chen, S. Zhu, Y. Chen, H. Huang, C. Yang, et al. CRLF1 bridges AKT and mTORC2 through SIN1 to inhibit pyroptosis and enhance chemo-resistance in ovarian cancer. Cell Death Dis. 15(2024):662.","DOI":"10.1038\/s41419-024-07035-4"},{"key":"10.1016\/j.bcp.2026.117876_b0080","doi-asserted-by":"crossref","first-page":"9656","DOI":"10.1038\/s41598-025-93519-y","article-title":"PNO1 enhances ovarian cancer cell growth, invasion, and stemness via activating the AKT\/Wnt\/\u03b2-catenin pathway","volume":"15","author":"Qin","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2026.117876_b0085","first-page":"1210","article-title":"Inhibition of apoptosis through. AKT-mTOR pathway in ovarian cancer and renal cancer","volume":"15","author":"Chen","year":"2023","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bcp.2026.117876_b0090","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/mc.22816","article-title":"TGF\u2010\u03b2\u2010mediated LEFTY\/Akt\/GSK\u20103\u03b2\/Snail axis modulates epithelial\u2010mesenchymal transition and cancer stem cell properties in ovarian clear cell carcinomas","volume":"57","author":"Matsumoto","year":"2018","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.bcp.2026.117876_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.173887","article-title":"Berberine inhibits chemotherapy-exacerbated ovarian cancer stem cell-like characteristics and metastasis through GLI1","volume":"895","author":"Zhao","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2026.117876_b0100","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1039\/D2NP00091A","article-title":"Discovery and development of botanical natural products and their analogues as therapeutics for ovarian cancer","volume":"40","author":"Mize","year":"2023","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.bcp.2026.117876_b0105","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12951-021-00933-1","article-title":"Amplification of oxidative stress with lycorine and gold-based nanocomposites for synergistic cascade cancer therapy","volume":"19","author":"Hu","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bcp.2026.117876_b0110","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s13046-022-02503-1","article-title":"Correction: Lycorine hydrochloride inhibits cell proliferation and induces apoptosis through promoting FBXW7-MCL1 axis in gastric cancer","volume":"41","author":"Li","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2026.117876_b0115","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.talanta.2013.11.014","article-title":"Study on pharmacokinetic and tissue distribution of lycorine in mice plasma and tissues by liquid chromatography-mass spectrometry","volume":"119","author":"Ren","year":"2014","journal-title":"Talanta"},{"key":"10.1016\/j.bcp.2026.117876_b0120","doi-asserted-by":"crossref","first-page":"10566","DOI":"10.1002\/jcp.27732","article-title":"Lycorine inhibits melanoma cell migration and metastasis mainly through reducing intracellular levels of \u03b2\u2010catenin and matrix metallopeptidase 9","volume":"234","author":"Zhang","year":"2019","journal-title":"Journal Cellular Physiology."},{"key":"10.1016\/j.bcp.2026.117876_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176162","article-title":"Lycorine eliminates B-cell acute lymphoblastic leukemia cells by targeting PSAT1 through the serine\/glycine metabolic pathway","volume":"961","author":"Liu","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2026.117876_b0130","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/bjh.16477","article-title":"Lycorine targets multiple myeloma stem cell\u2010like cells by inhibition of Wnt\/\u03b2\u2010catenin pathway","volume":"189","author":"Wang","year":"2020","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcp.2026.117876_b0135","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.7150\/thno.15584","article-title":"Lycorine Downregulates HMGB1 to Inhibit Autophagy and Enhances Bortezomib activity in Multiple Myeloma","volume":"6","author":"Roy","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.bcp.2026.117876_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216364","article-title":"Lycorine promotes IDH1 acetylation to induce mitochondrial dynamics imbalance in colorectal cancer cells","volume":"573","author":"Zhuo","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bcp.2026.117876_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157657","article-title":"Lycorine suppresses hepatocellular carcinoma via the reprogramming of myeloid and epithelial cells","volume":"150","author":"Gu","year":"2026","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bcp.2026.117876_b0150","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1158\/0008-5472.CAN-20-1488","article-title":"Frizzled-7 Identifies Platinum-Tolerant Ovarian Cancer Cells Susceptible to Ferroptosis","volume":"81","author":"Wang","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.117876_b0155","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009636","article-title":"DLL4-targeted CAR-T therapy sensitizes neoadjuvant chemotherapy via eliminating cancer stem cells and reshaping immune microenvironment in HER2+ breast cancer","volume":"12","author":"Yan","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bcp.2026.117876_b0160","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41392-022-00945-9","article-title":"MrgprF acts as a tumor suppressor in cutaneous melanoma by restraining PI3K\/Akt signaling","volume":"27","author":"Shen","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bcp.2026.117876_b0165","doi-asserted-by":"crossref","DOI":"10.1172\/JCI184721","article-title":"IGFBP6 orchestrates antiinfective immune collapse in murine sepsis via prohibitin-2-mediated immunosuppression","volume":"135","author":"Chen","year":"2025","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2026.117876_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115484","article-title":"PRMT5-mediated methylation of METTL3 promotes cisplatin resistance in ovarian cancer by facilitating DNA repair mechanisms","volume":"44","author":"Xia","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.bcp.2026.117876_b0175","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.semcancer.2019.08.014","article-title":"Natural product-based nanoformulations for cancer therapy: Opportunities and challenges","volume":"69","author":"Kashyap","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bcp.2026.117876_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110546","article-title":"Targeting miRNAs by natural products: a new way for cancer therapy","volume":"130","author":"Zhang","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2026.117876_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105778","article-title":"Biological effects and mechanisms of matrine and other constituents of Sophora flavescens in colorectal cancer","volume":"171","author":"Chen","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2026.117876_b0190","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/med.21346","article-title":"Therapeutic potential of Steroidal Alkaloids in Cancer and Other Diseases","volume":"36","author":"Jiang","year":"2016","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bcp.2026.117876_b0195","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3390\/ijms23010450","article-title":"Wnt\/\u03b2-Catenin Signaling Contributes to Paclitaxel Resistance in Bladder Cancer Cells with Cancer Stem Cell-like Properties","volume":"23","author":"Jim\u00e9nez-Guerrero","year":"2021","journal-title":"IJMS"},{"key":"10.1016\/j.bcp.2026.117876_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114350","article-title":"Luteolin directly binds to KDM4C and attenuates ovarian cancer stemness via epigenetic suppression of PPP2CA\/YAP axis","volume":"160","author":"Li","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2026.117876_b0205","doi-asserted-by":"crossref","first-page":"7007","DOI":"10.7150\/thno.98389","article-title":"BATF2 inhibits the stem cell-like properties and chemoresistance of gastric cancer cells through PTEN\/AKT\/\u03b2-catenin pathway","volume":"14","author":"Cao","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.bcp.2026.117876_b0210","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41392-024-01851-y","article-title":"Cancer stem cells: advances in knowledge and implications for cancer therapy","volume":"9","author":"Chu","year":"2024","journal-title":"Sig Transduct Target Ther."},{"key":"10.1016\/j.bcp.2026.117876_b0215","first-page":"1686","article-title":"Everolimus combined with 5-aza-2-deoxycytidine generated potent anti-tumor effects on ovarian clear cell cancer stem-like\/spheroid cells by inhibiting the COL6A3-AKT-mTOR pathway","volume":"12","author":"Ho","year":"2022","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.bcp.2026.117876_b0220","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s13046-024-03083-y","article-title":"Integrin-linked kinase-frizzled 7 interaction maintains cancer stem cells to drive platinum resistance in ovarian cancer","volume":"43","author":"Atwani","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2026.117876_b0225","doi-asserted-by":"crossref","DOI":"10.1172\/JCI186467","article-title":"SOX9 drives a stem-like transcriptional state and platinum resistance in high-grade serous ovarian cancer","volume":"135","author":"Duval","year":"2025","journal-title":"J. Clin. Investig."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522600208X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522600208X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T22:15:10Z","timestamp":1778710510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629522600208X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":45,"alternative-id":["S000629522600208X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117876","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lycorine suppresses cell growth and attenuates stemness through PI3K\/AKT pathway in ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117876","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117876"}}